| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-08-21 | HEIDEN WILLIAM K Director | Purchase | +100,000 | +909.09%111,000 | $1.51 | $150,515 | View SEC filing | |
| 2025-02-19 | Smith Beth Ann VP, Controller & Treasurer | Sale | -423 | -4.25%9,532 | $2.56 | $1,083 | View SEC filing | |
| 2024-04-08 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale | -51,395 | -100.00%0 | $15.55 | $799,148 | View SEC filing | |
| 2024-03-08 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale | -19,625 | -68.81%8,895 | $21.50 | $421,938 | View SEC filing | |
| 2024-03-06 | Risser Eric Blasius Chief Operating Officer | Sale | -41,159 | -51.41%38,900 | $19.76 | $813,501 | View SEC filing | |
| 2024-03-06 | Spitznagel Thomas Sr VP, Technical Ops | Sale | -10,000 | -54.60%8,316 | $20.00 | $200,000 | View SEC filing | |
| 2024-03-06 | Karrels James SVP, CFO and Secretary | Sale | -30,000 | -14.89%171,452 | $20.50 | $615,000 | View SEC filing | |
| 2024-02-28 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale | -16,124 | -64.45%8,895 | $17.22 | $277,655 | View SEC filing | |
| 2024-02-07 | Bonvini Ezio Sr VP, Research & CSO | Sale | -3,334 | -4.47%71,334 | $18.00 | $60,012 | View SEC filing | |
| 2024-02-07 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale | -76,251 | -100.00%0 | $16.50 | $1,258,142 | View SEC filing | |
| 2024-02-02 | Bonvini Ezio Sr VP, Research & CSO | Sale | -13,316 | -15.13%74,668 | $15.00 | $199,740 | View SEC filing | |
| 2024-01-22 | Bonvini Ezio Sr VP, Research & CSO | Sale | -13,316 | -13.15%87,984 | $12.00 | $159,792 | View SEC filing | |
| 2023-12-21 | Bonvini Ezio Sr VP, Research & CSO | Sale | -18,880 | -15.71%101,300 | $10.08 | $190,310 | View SEC filing | |
| 2023-10-04 | BB BIOTECH AG 10% Owner | Purchase | +150,000 | +1.53%9,929,963 | $4.46 | $669,585 | View SEC filing | |
| 2023-09-11 | BB BIOTECH AG 10% Owner | Purchase | +200,000 | +2.09%9,779,963 | $5.26 | $1,052,840 | View SEC filing | |
| 2023-09-01 | HURWITZ EDWARD Director | Purchase | +15,000 | +82.99%33,074 | $4.91 | $73,650 | View SEC filing | |
| 2023-03-14 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale | -5,372 | -100.00%0 | $6.03 | $32,393 | View SEC filing | |
| 2023-02-16 | BB BIOTECH AG 10% Owner | Purchase | +500,000 | +5.51%9,579,963 | $5.07 | $2,532,600 | View SEC filing | |
| 2023-01-23 | BB BIOTECH AG 10% Owner | Purchase | +150,000 | +1.68%9,079,963 | $5.30 | $794,925 | View SEC filing | |
| 2022-12-28 | BB BIOTECH AG 10% Owner | Purchase | +400,000 | +4.69%8,929,963 | $5.75 | $2,298,600 | View SEC filing | |
| 2022-11-25 | BB BIOTECH AG 10% Owner | Purchase | +300,000 | +3.65%8,529,963 | $5.96 | $1,788,180 | View SEC filing | |
| 2022-10-25 | BB BIOTECH AG 10% Owner | Purchase | +500,000 | +6.47%8,229,963 | $4.50 | $2,247,600 | View SEC filing | |
| 2022-10-21 | BB BIOTECH AG 10% Owner | Purchase | +454,399 | +6.25%7,729,963 | $3.89 | $1,767,484 | View SEC filing | |
| 2022-06-17 | Karrels James SVP, CFO and Secretary | Purchase | +40,000 | +26.35%191,776 | $2.47 | $98,800 | View SEC filing | |
| 2021-11-23 | BB BIOTECH AG 10% Owner | Purchase | +200,000 | +2.83%7,275,564 | $18.50 | $3,700,320 | View SEC filing |
1-25 of 112
